Recently Kazantseva et al. showed that the expression of Δ133p53β, which was increased in glioblastoma tissues with WT p53, promoted an immunosuppressive tumour microenvironment by increasing CCL2 expression and subsequent CD163 macrophage infiltration [102]. The gene discussed is TP53; the disease is neoplasm.